Title: Anthony A. McKinney: Innovator in Pharmaceutical Formulations
Introduction
Anthony A. McKinney is a notable inventor in the field of pharmaceuticals, particularly recognized for his innovative approaches to layered pharmaceutical formulations. His work focuses on enhancing the effectiveness of medications through unique delivery systems. Despite having no patents to his name, his contributions to the industry are significant.
Latest Patents
Anthony A. McKinney's latest patents include two key innovations. The first is titled "Layered Pharmaceutical Formulations," which describes a formulation that consists of two or more pharmaceutical layers with an intermediate layer designed to dissolve in vivo. This design allows the pharmaceutical layers to remain intact while delivering active ingredients such as bupropion, zonisamide, naltrexone, topiramate, phentermine, metformin, olanzapine, and fluoxetine. The second patent, "Methods For Administering Weight Loss Medications," outlines methods and systems for administering pharmaceuticals using a unit dosage package that contains varying amounts of drugs aimed at weight loss. These innovations reflect his commitment to improving patient outcomes through advanced pharmaceutical technologies.
Career Highlights
Throughout his career, Anthony A. McKinney has worked with prominent companies in the pharmaceutical sector. He has been associated with Orexigen Therapeutics, Inc. and Nalpropion Pharmaceuticals LLC, where he contributed to the development of innovative weight loss medications. His expertise in pharmaceutical formulations has made him a valuable asset in these organizations.
Collaborations
Anthony has collaborated with various professionals in the industry, including Gary Dennis Tollefson, enhancing the scope and impact of his work.
Conclusion
Anthony A. McKinney's contributions to pharmaceutical innovations demonstrate his dedication to improving medication delivery systems. His work continues to influence the field, paving the way for future advancements in pharmaceuticals.